A carregar...

Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study

BACKGROUND: Erythropoietic protoporphyria (EPP) is an ultra-rare genetic disorder (prevalence 1:150`000) characterized by instant painful phototoxic burn reactions in skin exposed to visible light. Afamelanotide is the first clinically tested therapy effectively increasing the time EPP patients can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Barman-Aksözen, Jasmin, Nydegger, Michèle, Schneider-Yin, Xiaoye, Minder, Anna-Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7437008/
https://ncbi.nlm.nih.gov/pubmed/32811524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01505-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!